POLI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 5.647
AS - Asia 5.311
EU - Europa 4.650
SA - Sud America 1.249
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 8
Totale 17.089
Nazione #
US - Stati Uniti d'America 5.437
RU - Federazione Russa 2.606
CN - Cina 1.837
SG - Singapore 1.828
BR - Brasile 1.050
HK - Hong Kong 673
SE - Svezia 595
VN - Vietnam 423
IT - Italia 337
RO - Romania 268
FR - Francia 265
DE - Germania 166
BD - Bangladesh 137
GB - Regno Unito 100
CA - Canada 98
IN - India 98
FI - Finlandia 83
AR - Argentina 72
IE - Irlanda 55
MX - Messico 51
ID - Indonesia 50
ZA - Sudafrica 41
EC - Ecuador 40
TR - Turchia 34
IQ - Iraq 33
NL - Olanda 33
AT - Austria 31
JP - Giappone 28
PL - Polonia 27
ES - Italia 25
MY - Malesia 22
UA - Ucraina 19
VE - Venezuela 19
MA - Marocco 18
PY - Paraguay 18
CO - Colombia 16
JM - Giamaica 16
PK - Pakistan 16
UZ - Uzbekistan 16
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
CL - Cile 12
PH - Filippine 12
EG - Egitto 11
KE - Kenya 10
NP - Nepal 10
PE - Perù 10
TW - Taiwan 10
CR - Costa Rica 9
DZ - Algeria 9
AU - Australia 7
IL - Israele 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
HN - Honduras 6
KZ - Kazakistan 6
LT - Lituania 6
AL - Albania 5
BB - Barbados 5
IR - Iran 5
TH - Thailandia 5
AM - Armenia 4
AZ - Azerbaigian 4
BO - Bolivia 4
GA - Gabon 4
GT - Guatemala 4
NG - Nigeria 4
NI - Nicaragua 4
UG - Uganda 4
BE - Belgio 3
BG - Bulgaria 3
JO - Giordania 3
LB - Libano 3
MD - Moldavia 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KR - Corea 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AO - Angola 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
Totale 16.967
Città #
Dallas 1.552
Singapore 735
Hong Kong 667
Ashburn 589
San Jose 561
Moscow 560
Council Bluffs 269
Shanghai 268
Hefei 253
Lawrence 229
Princeton 229
Lauterbourg 219
Ho Chi Minh City 168
New York 159
Los Angeles 129
Beijing 126
Santa Clara 98
Milan 88
São Paulo 85
Hanoi 83
Helsinki 61
Denver 51
Dublin 51
The Dalles 48
Phoenix 43
Orem 39
Nuremberg 37
Brooklyn 35
Montreal 35
Washington 35
Houston 34
Pune 34
Rome 34
Belo Horizonte 32
Boardman 31
Guangzhou 30
Munich 30
Seattle 30
Chicago 28
Columbus 28
Rio de Janeiro 28
Brasília 26
Tokyo 26
Atlanta 25
Boston 25
Haiphong 25
Warsaw 23
Curitiba 21
San Francisco 21
Stockholm 21
Chennai 20
Frankfurt am Main 18
London 17
Mexico City 17
Poplar 17
Toronto 17
Turku 17
Dhaka 16
Guayaquil 16
Kuala Lumpur 16
Shenzhen 16
Tashkent 16
Tianjin 16
Amsterdam 15
Johannesburg 14
Las Vegas 14
Porto Alegre 14
Xi'an 14
Salvador 13
Miami 12
Baghdad 11
Hangzhou 11
Jakarta 11
Vienna 11
Ankara 10
Campinas 10
Charlotte 10
Da Nang 10
Guarulhos 10
Ribeirão Preto 10
Biên Hòa 9
Buenos Aires 9
Cape Town 9
Caxias do Sul 9
Fortaleza 9
Hải Dương 9
Joinville 9
Mumbai 9
Pittsburgh 9
Quito 9
Zhengzhou 9
Fuzhou 8
Jeddah 8
Juiz de Fora 8
Kassel 8
Kingston 8
Manaus 8
Manchester 8
Nairobi 8
Oklahoma City 8
Totale 8.644
Nome #
1,25-dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-Kappa B-independent enhancement of viral replication 1.441
SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION IN CHRONICALLY INFECTED MONOCYTIC CELLS BY GLUTATHIONE, GLUTATHIONE ESTER, AND N-ACETYLCYSTEINE 693
Origin and evolution of SARS-CoV-2 154
Biobanking for COVID-19 research 149
Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection 135
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 135
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 129
Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4) 127
Human Monocyte-Derived Macrophages (MDM): Model 2 126
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 126
ACTIVATED LYMPHOCYTES-B FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS INDUCE VIRUS EXPRESSION IN INFECTED T-CELLS AND A PROMONOCYTIC CELL-LINE, U1 120
Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells 117
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 115
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. 109
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity 107
Restriction of Zika Virus Replication in Human Monocyte-Derived Macrophages by Pro-Inflammatory (M1) Polarization 103
A PLATELET-ACTIVATING-FACTOR ANTAGONIST, RP-55778, INHIBITS CYTOKINE-DEPENDENT INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION IN CHRONICALLY INFECTED PROMONOCYTIC CELLS 103
Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens 102
Association between the presence of CCR5-specific antibodies and long term non progression 102
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. 102
A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS 100
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 99
An approach to HIV gene therapy by transduction of multifunctional retroviral vectors in primary human T Lymphocytes 98
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1 97
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 97
Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus 92
[Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon]. FT Incremento transitorio dei linfociti OKT4+ in sangue periferico di pazienti affetti da LAS trattati con IFN-beta. 91
ALPHA-INTERFERON SUPPRESSES VIRION BUT NOT SOLUBLE HUMAN-IMMUNODEFICIENCY-VIRUS ANTIGEN PRODUCTION IN CHRONICALLY INFECTED T-LYMPHOCYTIC CELLS 91
Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells 87
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. 86
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls 86
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load (Nature, (2023), 620, 7976, (1025-1030), 10.1038/s41586-023-06370-4) 85
The Long and Winding Road towards an HIV Cure 83
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 81
Africa-specific human genetic variation near CHD1L associates with HIV-1 load 80
Asymmetric HIV-1 co-receptor use and replication in CD4+ T lymphocytes 80
INTERFERON-GAMMA INDUCES THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERSISTENTLY INFECTED PROMONOCYTIC CELLS (U1) AND REDIRECTS THE PRODUCTION OF VIRIONS TO INTRACYTOPLASMIC VACUOLES IN PHORBOL-MYRISTATE ACETATE DIFFERENTIATED U1 CELLS 78
M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms 77
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection 76
Coronaviridae and SARS-associated coronavirus strain HSR1 76
Preface 75
Preface 74
Retroviruses and opportunistic infections--eighth annual conference--structured therapy interruption. 74
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines 74
TRIM22. A multitasking antiviral factor 74
Efficient macrophage isolation of human immunodeficiency virus from peripheral blood leukocytes from healthy seropositive individuals: implications for cell tropism. 73
Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency 72
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection 72
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells 71
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy 71
Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer 71
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication 71
Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor 70
Engagement of CD30 shapes the secretion of cytokines by human gamma delta T cells 70
Bacterial toxins: Potential weapons against HIV infection 70
Zika Virus: a re-emerging pathogen with rapidly evolving public health implications 70
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 70
INTERFERONS IN THE PATHOGENESIS AND TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 69
Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4+T lymphocytes, a transcriptome analysis 68
Erratum: Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements" (Journal of virology (2011) 85 10 DOI: 10.1128/JVI.02302-10.) 68
Laureate ESCI award for excellence in clinical science 1999: cytokines and the human immunodeficiency virus: from bench to bedside 68
FP-21399 (Lexigen Pharmaceuticals). 68
Cytokine modulation of HIV expression. 68
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. 68
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands 68
SARS-CoV-2 Modulation of HIV Latency Reversal in a Myeloid Cell Line: Direct and Bystander Effects 67
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 67
IMMUNOPATHOGENIC MECHANISMS IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION 67
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease 66
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection 66
Mononuclear phagocytes and HIV infection 66
Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1CD4(+) T cells 66
Macrophage polarization and HIV-1 infection 65
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein 65
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives 64
Restricted replication of non-syncytium-inducing HIV in Th1 and Th2 lymphocytes 64
Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism 64
PRO-140 (Progenics). 63
IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 63
HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines 63
Chronically infected T-cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1 63
MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression 62
Role of cytokines and chemokines in the regulation of innate immunity and HIV infection 62
Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation 62
Unsung Hero Robert C. Gallo 62
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat 62
The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages 61
Preparing for phase II/III HIV vaccine trials in Africa 61
RECOMBINANT GP120 SPECIFICALLY ENHANCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND IG SECRETION IN LYMPHOCYTES-B FROM HIV-INFECTED INDIVIDUALS BUT NOT FROM SERONEGATIVE DONORS 61
Vaccine adjuvants: A priority for vaccine research 61
ULTRAVIOLET-IRRADIATION AND CYTOKINES AS REGULATORS OF HIV LATENCY AND EXPRESSION 60
Immunologic reconstitution by interleukin-2: facts and open questions 60
Role of pro-inflammatory cytokines and beta-chemokines in controlling HIV replication 60
INTERLEUKIN-1 INDUCES EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ALONE AND IN SYNERGY WITH INTERLEUKIN-6 IN CHRONICALLY INFECTED U1 CELLS - INHIBITION OF INDUCTIVE EFFECTS BY THE INTERLEUKIN-1 RECEPTOR ANTAGONIST 60
THE EFFECT OF CYTOKINES AND PHARMACOLOGICAL AGENTS ON CHRONIC HIV-INFECTION 60
U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency 59
Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection 59
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 59
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells 59
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells 59
Totale 9.990
Categoria #
all - tutte 109.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022110 0 0 0 59 16 3 4 5 1 3 3 16
2022/20231.174 540 237 94 8 10 108 56 57 25 4 30 5
2023/2024484 7 26 64 25 37 138 22 38 4 28 28 67
2024/20253.337 384 44 65 90 81 266 644 232 524 532 239 236
2025/202611.143 702 1.068 1.533 1.346 549 250 969 703 2.420 473 854 276
2026/2027804 306 498 0 0 0 0 0 0 0 0 0 0
Totale 17.089